Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rolake Akinsola"'
Autor:
Oche O Agbaji, Maxwell O Akanbi, Ihedinachi Otoh, Patricia E Agaba, Rolake Akinsola, Victoria Okolie, Placid O Ugoagwu, Aliyu A Babadoko, Adewumi Adediran, Finomo O Finomo, Jonah O Abah, Haruna M Muktar, Alani S Akanmu
Publikováno v:
Nigerian Postgraduate Medical Journal, Vol 26, Iss 4, Pp 195-198 (2019)
Background: The presence of human leukocyte antigen (HLA) B*57:01 allele predicts hypersensitivity reaction (HSR) to abacavir (ABC), a nucleoside reverse-transcriptase inhibitor used for human immunodeficiency virus (HIV) treatment. However, the prev
Externí odkaz:
https://doaj.org/article/5f99a2c29472494bafdee9bc0c4058d4
Autor:
Bobby Brooke Herrera, Donald J Hamel, Philip Oshun, Rolake Akinsola, Alani S Akanmu, Charlotte A Chang, Philomena Eromon, Onikepe Folarin, Kayode T Adeyemi, Christian T Happi, Yichen Lu, Folasade Ogunsola, Phyllis J Kanki
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 5, p e0006530 (2018)
Ebola virus (EBOV) caused more than 11,000 deaths during the 2013-2016 epidemic in West Africa without approved vaccines or immunotherapeutics. Despite its high lethality in some individuals, EBOV infection can produce little to no symptoms in others
Externí odkaz:
https://doaj.org/article/f357f06e159d42ea997d7eef49ed79bb
Autor:
AA Babadoko, Rolake Akinsola, V.O. Okolie, Maxwell O. Akanbi, Patricia E Agaba, Haruna M Muktar, Oche Agbaji, Finomo O Finomo, Jonah O Abah, Placid Ugoagwu, Adewumi Adediran, Alani S Akanmu, Ihedinachi Otoh
Publikováno v:
Nigerian Postgraduate Medical Journal. 26:195
Background: The presence of human leukocyte antigen (HLA) B*57:01 allele predicts hypersensitivity reaction (HSR) to abacavir (ABC), a nucleoside reverse-transcriptase inhibitor used for human immunodeficiency virus (HIV) treatment. However, the prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f25cea725373ed2a8bd6ddddd66f07b1
https://doi.org/10.4103/npmj.npmj_75_19
https://doi.org/10.4103/npmj.npmj_75_19
Autor:
Folasade Ogunsola, Phyllis J. Kanki, Rolake Akinsola, Bobby Brooke Herrera, Kayode T. Adeyemi, Alani S Akanmu, Christian T. Happi, Philomena Eromon, Yichen Lu, Donald J. Hamel, Philip O Oshun, Onikepe A. Folarin, Charlotte A. Chang
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 12, Iss 5, p e0006530 (2018)
PLoS Neglected Tropical Diseases, Vol 12, Iss 5, p e0006530 (2018)
Background Ebola virus (EBOV) caused more than 11,000 deaths during the 2013–2016 epidemic in West Africa without approved vaccines or immunotherapeutics. Despite its high lethality in some individuals, EBOV infection can produce little to no sympt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed4b55981d018670a8b5f4923c4f743b
https://doi.org/10.1371/journal.pntd.0006530
https://doi.org/10.1371/journal.pntd.0006530